Approved Study Database

Ref. No. Scientific Title Principal investigator
2013.256 Phase 2 study on safety and efficacy of irreversible electroporation for inoperable hepatic and pancreatic malignancy Prof. YU Simon
2006.310 Phase 2 Study of SU011248 in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Prof. Chan T.C. Anthony
2024.379 Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements Prof. CHAN Stephen Lam
2010.253 Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Prof. CHAN Anthony
2021.280 Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Prof. LI Chi Kong
李志光
2018.123 Phase 1b/2 Safety, Pharmacokinetic, and Efficacy Study of G1T38 in Combination with Osimertinib in Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) Prof. MOK Tony Shu Kam
莫樹錦
2017.661 PHASE 1/2 STUDY OF TAS-120 IN PATIENTS WITH ADVANCED SOLID TUMORS HARBORING FGF/FGFR ABERRATIONS Dr. CHAN Stephen Lam
陳林醫生
2014.528 Phase 1/2 Study of PF-06463922 (An ALK/ROS1 Tyrosine Kinase Inhibitor) in Patients with Advanced Non-Small Cell Lung Cancer Harboring Specific Molecular Alterations Prof. MOK Tony Shu Kam
2019.342 Phase 1/2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination with Pembrolizumab in Advanced Cancer Prof. MA Brigette Buig Yue
馬碧如教授
2007.312 Phase 1 Study of OPB-31121 in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma Dr. Lei I.K. Kenny
2010.596 Phase 1 Randomised study to assess immunogenicity, reactogenecity, safety and tolerability of two pneumococcal conjugate vaccines administered intraderamlly and intramuscularly to adults aged 20 to 50 years Prof NELSON Edmund A.S.
2024.106 Phase 1 randomised controlled clinical trial testing the safety and efficacy of CPP-anti-VEGF for the treatment of neovascular age-related macular degeneration Dr. BRELEN Mårten Erik
2012.337 Phase 1 Clinical Trial to Establish the Safety and Feasibility of Brain Transplants of Umbilical Cord Blood Mononuclear Cells in Chronic Ischemic Stroke Prof. POON Wai Sang
2018.582 Pharmacological Treatment of Mitochondrial Dysfunction in Diabetic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2008.180 Pharmacokinetics, Pharmacogenomics and Toxicity of Efavirenz in Chinese Patients with HIV Infection Prof. LEE Shui Shan
2016.263 Pharmacokinetics study of Trazodone Hydrochloride Prolonged-release tablets in Chinese Healthy Volunteers Dr. LUK Andrea On Yan
2006.462 Pharmacokinetics of Single and Repeated Oral Administration of S 33138 20 mg Daily in Chinese Healthy Male and Female Volunteers Prof. Tomlinson Brian
2005.370 Pharmacokinetics of Single and Repeated Oral Administration of S 18886 30mg Daily in Chinese Healthy Male Volunteers Prof. Brian Tomlinson
2011.158 Pharmacokinetics of Oseltamivir in Adult Chinese Hospitalized for Severe Influenza Infection and its Impact on Viral Clearance Dr Lee Nelson
2020.284 Pharmacokinetics and safety profile of Apixaban in patients with peritoneal dialysis Dr. FUNG Winston Wing Shing
馮永丞
2023.034 Pharmacokinetic study of vancomycin and meropenem and a pilot paediatric antibiotic stewardship program Prof. NG Wai Yin
吳煒燕
2013.407 Pharmacokinetic study of once-daily formulation of Tacrolimus (Advagraf_) in Chinese kidney transplant patients Dr Ma King Wing, Terry
2007.452 Pharmacokinetic Study of Doxorubicin Delivered Through Transarterial Administered of Four Different Doxorubicin-Loaded Formulations for Hepatocellular Carcinoma Dr Yu Simon
2011.390 Pharmacokinetic interaction between rosuvastatin and telmisartan Prof. TOMLINSON Brian
2019.688 Pharmacokinetic and pharmacodynamic study of a novel sublingual aspirin tablet compared to conventional oral aspirin in healthy subjects Prof. CHOW Elaine
2004.291 Pharmacokinetic and Pharmacodynamic Effects of a Special Buffered Propranolol Formulation for Sublingual Administration Prof. Chow S.S. Moses
2010.322 Pharmacogenomics of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidemia Prof Tomlinson Brian
2010.163 Pharmacogenomics of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidemia Prof Tomlinson Brian
2011.472 Pharmacogenomics of Niacin in Patients with Erectile Dysfunction and Dyslipidaemia - a Follow-on Study Prof Tomlinson Brian
2013.052 Pharmacogenomics of anti-hypertensive treatment in Chinese, from unpredictable response to personalized medicine Prof Tomlinson Brian
2022.524 Pharmacogenomics in childhood leukemia: a retrospective study Dr. LEUNG Kam Tong
2004.060 Pharmacogenetics of Warfarin Elimination and its Clinical Implications in Chinese Patients YOU Hoi Sze Joyce
2006.147 Pharmacogenetics of HMG Co-A Reductase Inhibitors in Chinese Patients with Hyperlipidaemia: A Combined Pharmacodynamic Pharmacokinetic Approach Prof. TOMLINSON Brian
2006.315 Pharmacogenetics of Fluoxetine in Chinese Patients (Protocol No. RES-06-01) CHOW Sing Sum Moses
2004.401 Pharmacogenetics of Citalopram and Venlafaxine in Chinese Patients (Proposal of Research Project 2004/2005 - PHA 3611 PHARMACY CLERKSHIP/PROJECT) CHOW SS Moses
2013.418 Pharmacogenetics of antiretroviral therapy for HIV infection in Hong Kong Prof. CHAN Denise Pui Chung
2009.639 Pharmacogenetics of Angiotensin Converting Enzyme Inhibitor (ACEI)-Related Cough Prof. Brian Tomlinson
2010.525 Pharmacogenetic Analysis of the effects of Nicotinic acid and Fenofibrate on rEsidual carDiOvascular risks, liveR fat and carotid Atherosclerosis in Chinese patients treated with statins, a prospective randomized clinical trial Prof Tomlinson Brian
2016.623 Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong Dr. YAN Bryan Ping Yen
2014.679 Pharmacodynamics and Pharmacokinetics of Oseltamivir in Critically Ill Patients with Severe Influenza Dr. WONG Wai Tat
2012.339 Pharmacist Intervention and Screening of Potentially Inappropriate Medications on Hospitalized Geriatric Patients in Hong Kong Mr Mak Wun Cheung
2008.510 Phaco-Trabeculectomy with Adjunctive Intra-Vitreal Injection of Bevacizumab (Avastin). A Preliminary Study. Professor Lam Dennis Shun Chiu
2018.110 Perturbation of retinoic acid homeostasis in fetal programming of type 2 diabetes in offspring of diabetic pregnancy Prof. SHUM Alisa Sau Wun
沈秀媛
2014.670 Perturb and Observe: Examining the Role of the Frontal Cortex in Change Detection Using Stimultaneous Transcranial Magnetic Stimulation and Event-related Optical Signals Dr. TSE Chun Yu
2023.693 Perspectives on illness perception and self-management behaviours from patients with non-alcoholic fatty liver disease and healthcare professionals: An exploratory qualitative study Ms. MA Angel Cho Kan
2022.368 Perspectives of End-of-Life Patients and Their Family Members on Advance Care Planning in Hong Kong Dr Lee Jenny Shun Wah
2018.338 Personalized Risk-based Care and Education for Early Survivors of Childhood Cancer in Hong Kong (Phase 2) Dr. CHEUNG Yin Ting
張彥婷
2024.138 Personalized Rehabilitation Pathways to Maximal Motor Functional Return through an AI Recovery Prediction System for Diverse Stroke Survivors Prof. CHEUNG Vincent Chi Kwan
張智鈞
2019.029 Personalized Procedural Simulation for Transcatheter Aortic Valve Implantation using 3D Printed Models: A Randomized Clinical Trial Dr. LEE Pui Wai
李沛威
2021.282 Personalized intellectually stimulating intervention for cognitive maintenance and healthy ageing Dr. LEE Allen Ting Chun

Page 77 of 254.